Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 711

1.

Immunohistochemically Detected Expression of ATRX, TSC2, and PTEN Predicts Clinical Outcomes in Patients With Grade 1 and 2 Pancreatic Neuroendocrine Tumors.

Uemura J, Okano K, Oshima M, Suto H, Ando Y, Kumamoto K, Kadota K, Ichihara S, Kokudo Y, Maeba T, Nanno Y, Toyama H, Takada Y, Shimada M, Hanazaki K, Masaki T, Suzuki Y.

Ann Surg. 2019 Oct 9. doi: 10.1097/SLA.0000000000003624. [Epub ahead of print]

PMID:
31599805
2.

Impact of Reduced-Dose Prasugrel vs. Standard-Dose Clopidogrel on In-Hospital Outcomes of Percutaneous Coronary Intervention in 62,737 Patients with Acute Coronary Syndromes: A Nationwide Registry Study in Japan.

Akita K, Inohara T, Yamaji K, Kohsaka S, Numasawa Y, Ishii H, Amano T, Kadota K, Nakamura M, Maekawa Y.

Eur Heart J Cardiovasc Pharmacother. 2019 Oct 8. pii: pvz056. doi: 10.1093/ehjcvp/pvz056. [Epub ahead of print]

PMID:
31593213
3.

Very Short Dual Antiplatelet Therapy after Drug-eluting Stent Implantation in Patients with High Bleeding Risk: Insight from the STOPDAPT-2 Trial.

Watanabe H, Domei T, Morimoto T, Natsuaki M, Shiomi H, Toyota T, Ohya M, Suwa S, Takagi K, Nanasato M, Hata Y, Yagi M, Suematsu N, Yokomatsu T, Takamisawa I, Doi M, Noda T, Okayama H, Seino Y, Tada T, Sakamoto H, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Hanaoka KI, Morino Y, Kozuma K, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 investigators.

Circulation. 2019 Sep 27. doi: 10.1161/CIRCULATIONAHA.119.043613. [Epub ahead of print]

PMID:
31560216
4.

Long-Term Incidence and Details of Bleeding Events After Everolimus-Eluting Stent Implantation - 7-8-Year Outcomes.

Miura K, Shimada T, Ohya M, Murai R, Amano H, Kubo S, Tada T, Tanaka H, Fuku Y, Goto T, Kadota K.

Circ J. 2019 Sep 7. doi: 10.1253/circj.CJ-19-0494. [Epub ahead of print]

5.

A Powderization Process for Encapsulating with Functional Biomaterials Using Nozzleless Electrostatic Atomization.

Mori C, Kadota K, Shimosaka A, Yoshida M, Shirakawa Y.

J Food Sci. 2019 Sep;84(9):2482-2489. doi: 10.1111/1750-3841.14783. Epub 2019 Sep 2.

PMID:
31476025
6.

Preparation of Amorphous Composite Particles of Drugs with Ursodeoxycholic Acid as Preclinical Formulations.

Tanida S, Yoshimoto A, Yoshida M, Uchiyama H, Kadota K, Tozuka Y.

Chem Pharm Bull (Tokyo). 2019;67(9):921-928. doi: 10.1248/cpb.c18-00644.

7.

Surgical Ineligibility and Long-Term Outcomes in Patients With Severe Coronary Artery Disease.

Matsumura-Nakano Y, Shiomi H, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Ando K, Yamaji K, Shizuta S, Sakata R, Hanyu M, Shimamoto M, Komiya T, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators.

Circ J. 2019 Sep 25;83(10):2061-2069. doi: 10.1253/circj.CJ-19-0440. Epub 2019 Aug 22.

8.

Percutaneous coronary intervention versus coronary arterial bypass grafting in patients with multi-vessel coronary revascularization (from the CREDO-Kyoto PCI/CABG registry/cohort-2).

Watanabe H, Shiomi H, Morimoto T, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Tazaki J, Watanabe H, Natsuaki M, Minatoya K, Hanyu M, Komiya T, Kimura T; CREDO-Kyoto PCI/CABG registry/cohort-2 investigators.

Catheter Cardiovasc Interv. 2019 Aug 7. doi: 10.1002/ccd.28420. [Epub ahead of print]

PMID:
31389659
9.

Borohydride-containing coordination polymers: synthesis, air stability and dehydrogenation.

Kadota K, Duong NT, Nishiyama Y, Sivaniah E, Kitagawa S, Horike S.

Chem Sci. 2019 May 13;10(24):6193-6198. doi: 10.1039/c9sc00731h. eCollection 2019 Jun 28.

10.

Activation and Expression of Peroxisome Proliferator-Activated Receptor Alpha Are Associated with Tumorigenesis in Colorectal Carcinoma.

Morinishi T, Tokuhara Y, Ohsaki H, Ibuki E, Kadota K, Hirakawa E.

PPAR Res. 2019 Jul 3;2019:7486727. doi: 10.1155/2019/7486727. eCollection 2019.

11.

Synthesis of porous coordination polymers using carbon dioxide as a direct source.

Kadota K, Duong NT, Nishiyama Y, Sivaniah E, Horike S.

Chem Commun (Camb). 2019 Aug 14;55(63):9283-9286. doi: 10.1039/c9cc04771a. Epub 2019 Jul 17.

PMID:
31312827
12.

Accurate Classification of Differential Expression Patterns in a Bayesian Framework With Robust Normalization for Multi-Group RNA-Seq Count Data.

Osabe T, Shimizu K, Kadota K.

Bioinform Biol Insights. 2019 Jul 8;13:1177932219860817. doi: 10.1177/1177932219860817. eCollection 2019.

13.

Long-term outcomes of three-vessel coronary artery disease after coronary revascularization by percutaneous coronary intervention using second-generation drug-eluting stents versus coronary artery bypass graft surgery.

Hata R, Kubo S, Tsuneyoshi H, Shimamoto T, Kuwayama A, Ohya M, Shimada T, Miura K, Amano H, Otsuru S, Habara S, Tada T, Tanaka H, Fuku Y, Goto T, Komiya T, Kadota K.

Cardiovasc Interv Ther. 2019 Jul 10. doi: 10.1007/s12928-019-00599-5. [Epub ahead of print]

PMID:
31292929
14.

A simple blending with α-glycosylated naringin produces enhanced solubility and absorption of pranlukast hemihydrate.

Uchiyama H, Kadota K, Nakanishi A, Tandia M, Tozuka Y.

Int J Pharm. 2019 Aug 15;567:118490. doi: 10.1016/j.ijpharm.2019.118490. Epub 2019 Jul 1.

PMID:
31271814
15.

[Multiple Pulmonary Inflammatory Myofibroblastic Tumor].

Ikeda T, Nakano J, Kushida Y, Kadota K, Ishikawa R.

Kyobu Geka. 2019 May;72(5):367-370. Japanese.

PMID:
31268035
16.

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial.

Watanabe H, Domei T, Morimoto T, Natsuaki M, Shiomi H, Toyota T, Ohya M, Suwa S, Takagi K, Nanasato M, Hata Y, Yagi M, Suematsu N, Yokomatsu T, Takamisawa I, Doi M, Noda T, Okayama H, Seino Y, Tada T, Sakamoto H, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Hanaoka KI, Morino Y, Kozuma K, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 Investigators.

JAMA. 2019 Jun 25;321(24):2414-2427. doi: 10.1001/jama.2019.8145.

PMID:
31237644
17.

Association of Mineralocorticoid Receptor Antagonist Use With All-Cause Mortality and Hospital Readmission in Older Adults With Acute Decompensated Heart Failure.

Yaku H, Kato T, Morimoto T, Inuzuka Y, Tamaki Y, Ozasa N, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Toyofuku M, Seko Y, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Kimura T; KCHF Study Investigators.

JAMA Netw Open. 2019 Jun 5;2(6):e195892. doi: 10.1001/jamanetworkopen.2019.5892.

18.

Oxidation of P700 Induces Alternative Electron Flow in Photosystem I in Wheat Leaves.

Kadota K, Furutani R, Makino A, Suzuki Y, Wada S, Miyake C.

Plants (Basel). 2019 Jun 5;8(6). pii: E152. doi: 10.3390/plants8060152.

19.

Risk Factors and Long-Term Clinical Outcomes of Second-Generation Drug-Eluting Stent Thrombosis.

Kuramitsu S, Ohya M, Shinozaki T, Otake H, Horie K, Kawamoto H, Yamanaka F, Natsuaki M, Shiomi H, Nakazawa G, Ando K, Kadota K, Saito S, Kimura T.

Circ Cardiovasc Interv. 2019 Jun;12(6):e007822. doi: 10.1161/CIRCINTERVENTIONS.119.007822. Epub 2019 Jun 10.

PMID:
31177822
20.

Laryngeal squamous cell carcinoma and papilloma associated with Equus caballus papillomavirus 2 in a horse.

Hibi H, Hatama S, Obata A, Shibahara T, Kadota K.

J Vet Med Sci. 2019 Jul 19;81(7):1029-1033. doi: 10.1292/jvms.18-0461. Epub 2019 Jun 4.

21.

Risk stratification model for in-hospital death in patients undergoing percutaneous coronary intervention: a nationwide retrospective cohort study in Japan.

Inohara T, Kohsaka S, Yamaji K, Ishii H, Amano T, Uemura S, Kadota K, Kumamaru H, Miyata H, Nakamura M.

BMJ Open. 2019 May 22;9(5):e026683. doi: 10.1136/bmjopen-2018-026683.

22.

Improved water dispersibility and photostability in folic acid nanoparticles with transglycosylated naringin using combined processes of wet-milling and freeze-drying.

Semba K, Kadota K, Arima H, Nakanishi A, Tandia M, Uchiyama H, Sugiyama K, Tozuka Y.

Food Res Int. 2019 Jul;121:108-116. doi: 10.1016/j.foodres.2019.03.034. Epub 2019 Mar 15.

PMID:
31108730
23.

Limited Resection Is Associated With a Higher Risk of Locoregional Recurrence than Lobectomy in Stage I Lung Adenocarcinoma With Tumor Spread Through Air Spaces.

Kadota K, Kushida Y, Kagawa S, Ishikawa R, Ibuki E, Inoue K, Go T, Yokomise H, Ishii T, Kadowaki N, Haba R.

Am J Surg Pathol. 2019 Aug;43(8):1033-1041. doi: 10.1097/PAS.0000000000001285.

PMID:
31107717
24.

Alcohol septal ablation using myocardial contrast echocardiography on a patient with iodine contrast allergy.

Ikuta S, Kubo S, Kuwayama A, Kadota K.

Eur Heart J Case Rep. 2018 Mar 21;2(2):yty010. doi: 10.1093/ehjcr/yty010. eCollection 2018 Jun. No abstract available.

25.

Primary Percutaneous Coronary Intervention in Elderly Patients With Acute Myocardial Infarction - An Analysis From a Japanese Nationwide Claim-Based Database.

Uemura S, Okamoto H, Nakai M, Nishimura K, Miyamoto Y, Yasuda S, Tanaka N, Kohsaka S, Kadota K, Saito Y, Tsutsui H, Komuro I, Ikari Y, Ogawa H, Nakamura M.

Circ J. 2019 May 24;83(6):1229-1238. doi: 10.1253/circj.CJ-19-0004. Epub 2019 Apr 24.

26.

Clinical Impact of Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve on Japanese Population in the ADVANCE Registry.

Shiono Y, Matsuo H, Kawasaki T, Amano T, Kitabata H, Kubo T, Morino Y, Yoda S, Sakamoto T, Ito H, Shite J, Otake H, Tanaka N, Terashima M, Kadota K, Patel MR, Nieman K, Rogers C, Nørgaard BL, Bax JJ, Raff GL, Chinnaiyan KM, Berman DS, Fairbairn TA, Hurwitz Koweek LM, Leipsic J, Akasaka T.

Circ J. 2019 May 24;83(6):1293-1301. doi: 10.1253/circj.CJ-18-1269. Epub 2019 Apr 18.

27.

7-Year Outcomes of a Randomized Trial Comparing the First-Generation Sirolimus-Eluting Stent Versus the New-Generation Everolimus-Eluting Stent: The RESET Trial.

Shiomi H, Kozuma K, Morimoto T, Kadota K, Tanabe K, Morino Y, Akasaka T, Abe M, Takeji Y, Suwa S, Ito Y, Kobayashi M, Dai K, Nakao K, Tarutani Y, Taniguchi R, Nishikawa H, Yamamoto Y, Nakagawa Y, Ando K, Kobayashi K, Kawai K, Hibi K, Kimura T; RESET Investigators.

JACC Cardiovasc Interv. 2019 Apr 8;12(7):637-647. doi: 10.1016/j.jcin.2019.01.234.

PMID:
30947938
28.

Long-Term Outcomes of Drug-Eluting Stent Implantation After Rotational Atherectomy for Left Main Coronary Artery Bifurcation Lesions.

Fuku Y, Kadota K, Toyofuku M, Morimoto T, Ohya M, Higami H, Yamaji K, Muranishi H, Yamaji Y, Nishida K, Furukawa D, Tada T, Ko E, Ando K, Sakamoto H, Tamura T, Kawai K, Kimura T; AOI LMCA Stenting Registry Investigators.

Am J Cardiol. 2019 Jun 1;123(11):1796-1805. doi: 10.1016/j.amjcard.2019.03.002. Epub 2019 Mar 9.

PMID:
30929770
29.

TCC-GUI: a Shiny-based application for differential expression analysis of RNA-Seq count data.

Su W, Sun J, Shimizu K, Kadota K.

BMC Res Notes. 2019 Mar 13;12(1):133. doi: 10.1186/s13104-019-4179-2.

30.

Randomized comparison between 2-link cell design biolimus A9-eluting stent and 3-link cell design everolimus-eluting stent in patients with de novo true coronary bifurcation lesions: the BEGIN trial.

Yamawaki M, Muramatsu T, Ashida K, Kishi K, Morino Y, Kinoshita Y, Fujii T, Noguchi Y, Hosogi S, Kawai K, Hibi K, Shibata Y, Ohira H, Morita Y, Tarutani Y, Toda M, Shimada Y, Ikari Y, Ando J, Hikichi Y, Otsuka Y, Fuku Y, Ito S, Katoh H, Kadota K, Ito Y, Mitsudo K.

Heart Vessels. 2019 Aug;34(8):1297-1308. doi: 10.1007/s00380-019-01368-3. Epub 2019 Mar 11.

PMID:
30859377
31.

Post-interventional adverse event risk by vascular access site among patients with acute coronary syndrome in Japan: observational analysis with a national registry J-PCI database.

Fujii T, Ikari Y, Hashimoto H, Kadota K, Amano T, Uemura S, Takashima H, Nakamura M; J-PCI Investigators.

Cardiovasc Interv Ther. 2019 Oct;34(4):297-304. doi: 10.1007/s12928-019-00582-0. Epub 2019 Mar 7.

PMID:
30847655
32.

In-Hospital Outcomes After Percutaneous Coronary Intervention for Acute Coronary Syndrome With Cardiogenic Shock (from a Japanese Nationwide Registry [J-PCI Registry]).

Kubo S, Yamaji K, Inohara T, Kohsaka S, Tanaka H, Ishii H, Uemura S, Amano T, Nakamura M, Kadota K.

Am J Cardiol. 2019 May 15;123(10):1595-1601. doi: 10.1016/j.amjcard.2019.02.015. Epub 2019 Feb 22.

PMID:
30846213
33.

Comparison of Outcomes After Percutaneous Coronary Intervention in Elderly Patients, Including 10 628 Nonagenarians: Insights From a Japanese Nationwide Registry (J-PCI Registry).

Numasawa Y, Inohara T, Ishii H, Yamaji K, Kohsaka S, Sawano M, Kodaira M, Uemura S, Kadota K, Amano T, Nakamura M; J‐PCI Registry Investigators.

J Am Heart Assoc. 2019 Mar 5;8(5):e011183. doi: 10.1161/JAHA.118.011017.

34.

Association between J-CTO score and long-term target lesion revascularization rate after successful chronic total coronary occlusion angioplasty (from the J-CTO Registry).

Abe M, Morimoto T, Morino Y, Tanaka H, Akao M, Hayashi Y, Muramatsu T, Ochiai M, Noguchi Y, Yumoto K, Shibata Y, Hiasa Y, Doi O, Yamashita T, Hinohara T, Kadota K, Kimura T; J-CTO Registry Investigators.

Catheter Cardiovasc Interv. 2019 May 1;93(6):1025-1032. doi: 10.1002/ccd.28104. Epub 2019 Feb 5.

PMID:
30723999
35.

In-situ dissolution and permeation studies of nanocrystal formulations with second-derivative UV spectroscopy.

Imono M, Uchiyama H, Ueda H, Kadota K, Tozuka Y.

Int J Pharm. 2019 Mar 10;558:242-249. doi: 10.1016/j.ijpharm.2018.12.086. Epub 2019 Jan 14.

PMID:
30654061
36.

Solubility and Permeability Improvement of Quercetin by an Interaction Between α-Glucosyl Stevia Nanoaggregates and Hydrophilic Polymer.

Uchiyama H, Wada Y, Hatanaka Y, Hirata Y, Taniguchi M, Kadota K, Tozuka Y.

J Pharm Sci. 2019 Jun;108(6):2033-2040. doi: 10.1016/j.xphs.2019.01.007. Epub 2019 Jan 14.

PMID:
30653971
37.

[Pulmonary Fetal Adenocarcinoma Requiring Differential Diagnosis of Metastatic Lung Tumor;Report of a Case].

Ikeda T, Nakano J, Kadota K, Okada S.

Kyobu Geka. 2018 Dec;71(13):1133-1135. Japanese.

PMID:
30587758
38.

Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation.

Matsumura-Nakano Y, Shizuta S, Komasa A, Morimoto T, Masuda H, Shiomi H, Goto K, Nakai K, Ogawa H, Kobori A, Kono Y, Kaitani K, Suwa S, Aoyama T, Takahashi M, Sasaki Y, Onishi Y, Mano T, Matsuda M, Motooka M, Tomita H, Inoko M, Wakeyama T, Hagiwara N, Tanabe K, Akao M, Miyauchi K, Yajima J, Hanaoka K, Morino Y, Ando K, Furukawa Y, Nakagawa Y, Nakao K, Kozuma K, Kadota K, Kimura K, Kawai K, Ueno T, Okumura K, Kimura T; OAC-ALONE Study Investigators.

Circulation. 2019 Jan 29;139(5):604-616. doi: 10.1161/CIRCULATIONAHA.118.036768.

PMID:
30586700
39.

Development of porous particles using dextran as an excipient for enhanced deep lung delivery of rifampicin.

Kadota K, Yanagawa Y, Tachikawa T, Deki Y, Uchiyama H, Shirakawa Y, Tozuka Y.

Int J Pharm. 2019 Jan 30;555:280-290. doi: 10.1016/j.ijpharm.2018.11.055. Epub 2018 Nov 22.

PMID:
30471373
40.

An overview of percutaneous coronary intervention in dialysis patients: Insights from a Japanese nationwide registry.

Numasawa Y, Inohara T, Ishii H, Yamaji K, Hirano K, Kohsaka S, Sawano M, Kuno T, Kodaira M, Uemura S, Kadota K, Amano T, Nakamura M; J-PCI Registry Investigators.

Catheter Cardiovasc Interv. 2019 Jul 1;94(1):E1-E8. doi: 10.1002/ccd.27986. Epub 2018 Nov 23.

PMID:
30467967
41.

Erythroblastic sarcoma in the thoracic cavity of a cow.

Ogasawara F, Kumagai Y, Mikami O, Ishikawa Y, Kadota K.

J Vet Med Sci. 2019 Jan 25;81(1):134-137. doi: 10.1292/jvms.18-0413. Epub 2018 Nov 19.

42.

Acute Coronary Syndrome With Unprotected Left Main Coronary Artery Culprit - An Observation From the AOI-LMCA Registry.

Higami H, Toyofuku M, Morimoto T, Ohya M, Fuku Y, Yamaji K, Muranishi H, Yamaji Y, Nishida K, Furukawa D, Tada T, Ko E, Ando K, Sakamoto H, Tamura T, Kawai K, Kadota K, Kimura T; AOI-LMCA Stenting Registry Investigators.

Circ J. 2018 Dec 25;83(1):198-208. doi: 10.1253/circj.CJ-18-0896. Epub 2018 Nov 9.

43.

Clinical and angiographic outcomes of true vs. false lumen stenting of coronary chronic total occlusions: Insights from intravascular ultrasound.

Sabbah M, Tada T, Kadota K, Kubo S, Otsuru S, Hasegawa D, Habara S, Tanaka H, Fuku Y, Goto T.

Catheter Cardiovasc Interv. 2019 Feb 15;93(3):E120-E129. doi: 10.1002/ccd.27861. Epub 2018 Oct 22.

PMID:
30345649
44.

Cribriform Subtype is an Independent Predictor of Recurrence and Survival After Adjustment for the Eighth Edition of TNM Staging System in Patients With Resected Lung Adenocarcinoma.

Kadota K, Kushida Y, Kagawa S, Ishikawa R, Ibuki E, Inoue K, Go T, Yokomise H, Ishii T, Kadowaki N, Haba R.

J Thorac Oncol. 2019 Feb;14(2):245-254. doi: 10.1016/j.jtho.2018.09.028. Epub 2018 Oct 15.

PMID:
30336325
45.

Investigation of Physiological Properties of Transglycosylated Stevia with Cationic Surfactant and Its Application To Enhance the Solubility of Rebamipide.

Uchiyama H, Srivastava A, Fujimori M, Tomoo K, Nakanishi A, Tandia M, Kadota K, Tozuka Y.

J Phys Chem B. 2018 Nov 1;122(43):10051-10061. doi: 10.1021/acs.jpcb.8b07515. Epub 2018 Oct 19.

PMID:
30299943
46.

Rhinoceros beetle horn development reveals deep parallels with dung beetles.

Ohde T, Morita S, Shigenobu S, Morita J, Mizutani T, Gotoh H, Zinna RA, Nakata M, Ito Y, Wada K, Kitano Y, Yuzaki K, Toga K, Mase M, Kadota K, Rushe J, Lavine LC, Emlen DJ, Niimi T.

PLoS Genet. 2018 Oct 4;14(10):e1007651. doi: 10.1371/journal.pgen.1007651. eCollection 2018 Oct.

47.

Dynamic severe mitral regurgitation on hospital arrival as prognostic predictor in patients hospitalized for acute decompensated heart failure.

Kubo S, Kawase Y, Hata R, Maruo T, Tada T, Kadota K.

Int J Cardiol. 2018 Dec 15;273:177-182. doi: 10.1016/j.ijcard.2018.09.093. Epub 2018 Sep 27.

PMID:
30274752
48.

Demographics, Management, and In-Hospital Outcome of Hospitalized Acute Heart Failure Syndrome Patients in Contemporary Real Clinical Practice in Japan - Observations From the Prospective, Multicenter Kyoto Congestive Heart Failure (KCHF) Registry.

Yaku H, Ozasa N, Morimoto T, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Su K, Kawato M, Sasaki K, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Kato T, Kimura T; KCHF Study Investigators.

Circ J. 2018 Oct 25;82(11):2811-2819. doi: 10.1253/circj.CJ-17-1386. Epub 2018 Sep 26.

49.

Procedure-Specific Risk Prediction for Recurrence in Patients Undergoing Lobectomy or Sublobar Resection for Small (≤2 cm) Lung Adenocarcinoma: An International Cohort Analysis.

Bains S, Eguchi T, Warth A, Yeh YC, Nitadori JI, Woo KM, Chou TY, Dienemann H, Muley T, Nakajima J, Shinozaki-Ushiku A, Wu YC, Lu S, Kadota K, Jones DR, Travis WD, Tan KS, Adusumilli PS.

J Thorac Oncol. 2019 Jan;14(1):72-86. doi: 10.1016/j.jtho.2018.09.008. Epub 2018 Sep 22.

PMID:
30253972
50.

Bilateral Adrenocortical Adenomas along with Virilization and Cushing's Syndrome.

Kobayashi T, Imachi H, Sato S, Ibata T, Fukunaga K, Yoshimoto T, Kikuchi F, Yonezaki K, Yamaji N, Lyu J, Dong T, Nagata H, Kadota K, Kushida Y, Haba R, Murao K.

Intern Med. 2019 Feb 1;58(3):405-409. doi: 10.2169/internalmedicine.0790-18. Epub 2018 Sep 12.

Supplemental Content

Loading ...
Support Center